StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · SVRA·Healthcare

Savara Inc. Stock Analysis & AI Score

Savara Inc. (SVRA) has an ST Score of 48.6 (C+), driven by its Forecast (A-) and held back by its Profitability (D). Analysts rate it Buy with a $9.50 price target (+87.4% upside).

Market Closed
$5.07
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
49
ST Score
48.6/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

SVRA
48.6out of 100
Grade C+

Savara Inc. (SVRA) has an ST Score of 48.6 (C+), driven by its Forecast (A-) and held back by its Profitability (D). Analysts rate it Buy with a $9.50 price target (+87.4% upside).

Strongest
ForecastA-
Weakest
ProfitabilityD
All factor grades
  • ForecastA-
  • MomentumB+
  • Financial StrengthB
  • ValuationB-
  • GrowthC+
  • ProfitabilityD
  • Piotroski1/9
Score methodology
Press Releases

Contact

SVRA stock: frequently asked questions

What is SVRA's ST Score?

Savara Inc. (SVRA) has an ST Score of 48.6 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is SVRA a buy, hold, or sell?

Analysts rate SVRA a Buy, with a price target of $9.50 (+87.4% vs the current price). Our ST Score grades it C+ (48.6/100). The ST Score is a data-driven signal, not a recommendation.

What are SVRA's factor grades?

Valuation B-, Profitability D, Financial Strength B, Momentum B+, Growth C+, Forecast A-.

What is SVRA's valuation grade?

Savara Inc. (SVRA) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is SVRA's growth grade?

Savara Inc. (SVRA) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is SVRA's profitability grade?

Savara Inc. (SVRA) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is SVRA's financial strength grade?

Savara Inc. (SVRA) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for SVRA?

The average analyst price target for Savara Inc. (SVRA) is $9.50 from 11 analysts, which is +87.4% versus the recent price of $5.07.

What is SVRA's Piotroski score?

Savara Inc. (SVRA) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.